GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (XCNQ:TRUL) » Definitions » Debt-to-EBITDA

Trulieve Cannabis (XCNQ:TRUL) Debt-to-EBITDA : 2.69 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Trulieve Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$31 Mil. Trulieve Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$1,033 Mil. Trulieve Cannabis's annualized EBITDA for the quarter that ended in Dec. 2023 was C$395 Mil. Trulieve Cannabis's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.69.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Trulieve Cannabis's Debt-to-EBITDA or its related term are showing as below:

XCNQ:TRUL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -36.06   Med: 1.02   Max: 4.07
Current: -16.34

During the past 10 years, the highest Debt-to-EBITDA Ratio of Trulieve Cannabis was 4.07. The lowest was -36.06. And the median was 1.02.

XCNQ:TRUL's Debt-to-EBITDA is ranked worse than
100% of 660 companies
in the Drug Manufacturers industry
Industry Median: 1.665 vs XCNQ:TRUL: -16.34

Trulieve Cannabis Debt-to-EBITDA Historical Data

The historical data trend for Trulieve Cannabis's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis Debt-to-EBITDA Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 1.38 3.03 4.07 -36.06

Trulieve Cannabis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.82 6.63 -1.00 2.87 2.69

Competitive Comparison of Trulieve Cannabis's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's Debt-to-EBITDA falls into.



Trulieve Cannabis Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Trulieve Cannabis's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(30.763 + 1032.549) / -29.486
=-36.06

Trulieve Cannabis's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(30.763 + 1032.549) / 395.22
=2.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Trulieve Cannabis  (XCNQ:TRUL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Trulieve Cannabis Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis (XCNQ:TRUL) Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.

Trulieve Cannabis (XCNQ:TRUL) Headlines

From GuruFocus

Trulite Inc (TRUL) President and CEO Kim A. Rivers Bought $1 million of Shares

By GuruFocus Research GuruFocus Editor 06-16-2021

Trulite Inc (TRUL) President and CEO Kim A. Rivers Bought $97,936 of Shares

By GuruFocus Research GuruFocus Editor 08-18-2021

Is Trulite Inc Undervalued Following the Latest Insider Buy?

By GuruFocus Research GuruFocus Editor 05-26-2022